Intra-Cellular Therapies, Inc. $(ITCI)$ is currently at $127.68, up $32.81 or 34.58%
--Would be new all-time high (Based on available data back to Dec. 23, 2013)
--On pace for largest percent increase since Sept. 9, 2020, when it rose 72.87%
--Currently up three of the past four days
--Currently up two consecutive days; up 54.65% over this period
--Best two day stretch since the two days ending Sept. 10, 2020, when it rose 68.37%
--Up 52.87% month-to-date
--Up 52.87% year-to-date
--Up 92.41% from 52 weeks ago (Jan. 12, 2024), when it closed at $66.36
--Would be a new 52-week closing high
--Up 98.35% from its 52-week closing low of $64.37 on March 12, 2024
--Traded as high as $128.00; new all-time intraday high (Based on available data back to Dec. 23, 2013)
--Up 34.92% at today's intraday high; largest intraday percent increase since Sept. 9, 2020, when it rose as much as 83.07%
All data as of 10:53:22 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
January 13, 2025 10:55 ET (15:55 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。